发明名称 Glucose inducible insulin expression and methods of treating diabetes
摘要 The invention provides an isolated tissue specific glucose responsive promoter having a polymerase binding domain 3' to at least one tripartite transcription factor binding cis element having a hepatocyte nuclear factor-1 (HNF-1) element, a CAAT/enhancer binding protein (C/EBP) response element and a glucose-response element (GRE). The promoter can include a second or third tripartite transcription factor binding cis element. A host cell including the tissue specific glucose responsive promoter of the invention also are provided. Further provided is a method of treating or preventing diabetes. The method includes administering to an individual an effective amount of a viral particle having a vector comprising a tissue specific glucose responsive promoter comprising a polymerase binding domain 3' to at least one tripartite transcription factor binding cis element having a hepatocyte nuclear factor-1 (HNF-1) element, a CAAT/enhancer binding protein (C/EBP) response element and a glucose-response element (GRE) operationally linked to an insulin encoding nucleic acid, wherein expression of the insulin encoding nucleic acid is tissue specific and glucose responsive.
申请公布号 US2007020237(A1) 申请公布日期 2007.01.25
申请号 US20060443575 申请日期 2006.05.30
申请人 BIOTECH INSTITUTE FOR INTERNATIONAL INNOVATION, INC. 发明人 YOON CHUNGJA;YOON JI-WON;HAN JAESEOK
分类号 C12N5/08;A61K48/00;C12N15/86 主分类号 C12N5/08
代理机构 代理人
主权项
地址